intravenous l carnitine L-Carnitine L- Carnitine Injections - MD
Description
doi: 10.1016/0006-8993(88)90451-9
This cofactor acts as a platform that recruits additional transcription factors, such as nuclear respiratory factors 1 (NRF1) and 2 (NRF2) (Kaur and Sharma 2022)
Ye B.-C
Gallbladder disease: Incretin-based therapies have been associated with an increased risk of cholelithiasis (gallstones) and cholecystitis (gallbladder inflammation), as noted in the UK SmPCs for licensed comparators such as semaglutide and tirzepatide
